Triple
T16851984
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Biktarvy |
E409696
|
entity |
| Predicate | hasTradeName |
P24555
|
FINISHED |
| Object | Biktarvy |
E409696
|
NE FINISHED |
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Biktarvy Context triple: [Biktarvy, hasTradeName, Biktarvy]
-
A.
Biktarvy
chosen
Biktarvy is a prescription combination antiretroviral medication used to treat HIV-1 infection in adults and certain children.
-
B.
Vitrakvi
Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
-
C.
Bunefer
Bunefer was an ancient Egyptian queen of the late Fourth Dynasty, likely known from her tomb at Giza and associated with the royal family of that period.
-
D.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
-
E.
Skyrizi
Skyrizi is a prescription biologic medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and Crohn’s disease by targeting the interleukin-23 (IL-23) pathway.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d88395e6c88190b22730f335107c14 |
elicitation | completed |
| NER | batch_69e3b379b8fc81908d8bc9950c7f8bad |
ner | completed |
| NED1 | batch_6a00bb216fac81909d401c6b9911d1e0 |
ned_source_triple | completed |
Created at: April 10, 2026, 5:24 a.m.